Lu, Y., Parker, L. L., Lu, T., Zheng, Z., Toomey, M. A., White, D. E., . . . Rosenberg, S. A. (2017). Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3. J Clin Oncol.
Citação norma ChicagoLu, Yong-Chen, et al. "Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3." J Clin Oncol 2017.
MLA citiranjeLu, Yong-Chen, et al. "Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3." J Clin Oncol 2017.
Opozorilo: Ti citati niso vedno 100% točni.